TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11729008

Group type: EXPERIMENTAL
Intervention: Combined psychotherapy and pharmacotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: One-person treatment model (psychiatrist conducts psychotherapy and prescribes medication)
Number of subjects: 0
Study: 9205763

Group type: EXPERIMENTAL
Intervention: ebrotidine (400 mg/day)
Number of subjects: 250

Group type: COMPARATOR
Intervention: ranitidine (300 mg/day in healing phase, 150 mg/day in follow-up phase)
Number of subjects: 250
Study: 8427866

Group type: EXPERIMENTAL
Intervention: Vessel wall shear stress calculated using a validated finite‐difference model of the Navier‐Stokes' equation with a coronary flow rate of 8 ml/sec.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low shear stress
Number of subjects: 20
Study: 3629187

Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 11

Group type: COMPARATOR
Intervention: Aluminium-containing antacid
Number of subjects: 11
Study: 30348912

Group type: EXPERIMENTAL
Intervention: VAMP-system flushing method
Number of subjects: 360

Group type: COMPARATOR
Intervention: Traditional flushing method with 10 ml syringe of saline
Number of subjects: 360
Study: 26774508

Group type: EXPERIMENTAL
Intervention: Enzalutamide 160 mg/day
Number of subjects: 375

Group type: COMPARATOR
Intervention: Bicalutamide 50 mg/day
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 375

Group type: COMPARATOR
Intervention: Bicalutamide
Number of subjects: 375
Study: 25015740

Group type: EXPERIMENTAL
Intervention: IORT as APBI according to ESTRO criteria
Number of subjects: 1108

Group type: EXPERIMENTAL
Intervention: IORT as APBI according to ASTRO criteria
Number of subjects: 1108

Group type: EXPERIMENTAL
Intervention: TARGIT E trial eligibility
Number of subjects: 1108

Group type: EXPERIMENTAL
Intervention: TARGIT C trial eligibility
Number of subjects: 1108

Group type: EXPERIMENTAL
Intervention: TARGIT BQR registry eligibility
Number of subjects: 1108

Group type: EXPERIMENTAL
Intervention: IORT as APBI treatment
Number of subjects: 1108

Group type: EXPERIMENTAL
Intervention: IORT boost treatment
Number of subjects: 1108
Study: 22146934

Group type: EXPERIMENTAL
Intervention: Focused imitation intervention
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study: 20691408

Group type: EXPERIMENTAL
Intervention: Simulation
Number of subjects: 38

Group type: COMPARATOR
Intervention: Lecture
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Simulation→Lecture
Number of subjects: 38
Study: 18936479

Group type: EXPERIMENTAL
Intervention: Full-dose reirradiation combined with chemotherapy (RT arm)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Observation (wait and see approach; WS arm)
Number of subjects: 130
Study: 15932528

Group type: EXPERIMENTAL
Intervention: Topical 0.1% dexamethasone eye drops four times daily (group A)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Topical 0.1% dexamethasone eye drops twice daily (group B)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 137
Study: 12598253

Group type: COMPARATOR
Intervention: Remifentanil alone
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Remifentanil combined with ketamine at 50 or 100 ng/mL
Number of subjects: 14

Group type: COMPARATOR
Intervention: Remifentanil at 2 ng/mL
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 14
Study: 10880799

Group type: EXPERIMENTAL
Intervention: HIV-positive subjects with CD4+ <200
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: HIV-positive subjects with CD4+ >400
Number of subjects: 56

Group type: COMPARATOR
Intervention: HIV-negative controls
Number of subjects: 56
Study: 8979390

Group type: EXPERIMENTAL
Intervention: Long-shot (high-risk, high-payoff) lottery preference
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rational analysis of lotteries
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risky tendencies in unpleasant moods
Number of subjects: 0
Study: 1734901

Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (MTX) at a mean weekly dosage of 10.2 mg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (MTX)
Number of subjects: 26
Study: 6524917

Group type: EXPERIMENTAL
Intervention: Moderate energy supplement (0 g protein, 420 kcal)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Protein supplement (14 g protein, 84 kcal)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 31862134

Group type: EXPERIMENTAL
Intervention: Electrochemotherapy (ECT)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 117
Study: 30335622

Group type: EXPERIMENTAL
Intervention: Parental engagement during skin-to-skin contact (SSC)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Maternal engagement scores during SSC
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Paternal oxytocin levels during SSC
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Paternal cortisol levels during SSC
Number of subjects: 28
Study: 28801395

Group type: EXPERIMENTAL
Intervention: Question Prompt Sheet (QPS)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Question List (QL)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 308
Study: 25579668

Group type: EXPERIMENTAL
Intervention: Multidisciplinary, coordinated and tailored RTW-intervention
Number of subjects: 168

Group type: COMPARATOR
Intervention: Conventional case management
Number of subjects: 168
Study: 23778773

Group type: EXPERIMENTAL
Intervention: Rib cage stabilization with an elastic band in the supine position
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Rib cage stabilization with an elastic band in the prone position
Number of subjects: 16

Group type: COMPARATOR
Intervention: Supine position without the elastic band
Number of subjects: 16

Group type: COMPARATOR
Intervention: Prone position without the elastic band
Number of subjects: 16
Study: 21646823

Group type: EXPERIMENTAL
Intervention: Motivational Intervention (MI) + Treatment as Usual (TAU)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 62
Study: 19701513

Group type: EXPERIMENTAL
Intervention: Etch-and-rinse with 37% H3PO4 for 10 s (group 7)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thermomechanical loading (TML)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No further pretreatment (group 5)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Use of a water cooled high-speed diamond bur (group 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diamond bur and etching (group 4)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Syntac and two consecutive layers of Tetric flow (groups 6 and 8)
Number of subjects: 0
Study: 16707195

Group type: EXPERIMENTAL
Intervention: Hepavax-Gene TF
Number of subjects: 770

Group type: EXPERIMENTAL
Intervention: Hepavax-Gene
Number of subjects: 770

Group type: COMPARATOR
Intervention: Engerix-B (control)
Number of subjects: 770
Study: 11989841

Group type: EXPERIMENTAL
Intervention: Octreotide 100 microg/h after an initial bolus of 100 microg plus terlipressin 2 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Terlipressin 2 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 10078672

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 10

Group type: COMPARATOR
Intervention: Alfentanil
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cold-pressor test
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Psychomotor test 60 min after remifentanil infusion
Number of subjects: 10
Study: 7733186

Group type: EXPERIMENTAL
Intervention: Surgeon fixation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Patient fixation
Number of subjects: 48
Study: 2342898

Group type: EXPERIMENTAL
Intervention: Waterbed flotation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard incubator mattress
Number of subjects: 22
Study: 6106148

Group type: EXPERIMENTAL
Intervention: Oxprenolol
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 7
Study: 6834205

Group type: EXPERIMENTAL
Intervention: Related play therapy
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Unrelated play therapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (no preoperative preparation)
Number of subjects: 45
Study: 29424008

Group type: EXPERIMENTAL
Intervention: 1 mg granisetron
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: 0.7 mg granisetron
Number of subjects: 212

Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Granisetron groups (1 mg and 0.7 mg)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Group I (0.9% saline)
Number of subjects: 212
Study: 29934199

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy plus standard care (10-14 sessions over 10 months)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 255
Study: 26655732

Group type: EXPERIMENTAL
Intervention: Low-dose cariprazine (1.5-4.5 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose cariprazine (6-12 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24613434

Group type: EXPERIMENTAL
Intervention: Fermented milk (FM) 80 mL/d
Number of subjects: 24

Group type: COMPARATOR
Intervention: Non-fermented milk (NFM) 80 mL/d
Number of subjects: 24
Study: 22804104

Group type: EXPERIMENTAL
Intervention: Celecoxib or nonselective NSAID plus PPI
Number of subjects: 3774

Group type: EXPERIMENTAL
Intervention: Baseline C-reactive protein (CRP) levels
Number of subjects: 3774

Group type: EXPERIMENTAL
Intervention: History of gastritis
Number of subjects: 3774

Group type: EXPERIMENTAL
Intervention: History of GI intolerance
Number of subjects: 3774

Group type: EXPERIMENTAL
Intervention: Positive Helicobacter pylori at screening
Number of subjects: 3774

Group type: EXPERIMENTAL
Intervention: Increasing age
Number of subjects: 3774

Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 3774
Study: 20498097

Group type: EXPERIMENTAL
Intervention: Various treatments for low libido in women (specific interventions not detailed)
Number of subjects: 0
Study: 18799936

Group type: EXPERIMENTAL
Intervention: anti-D immunoglobulin (50 microg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: intravenous immunoglobulin (IVIG, 1.0 g/kg/dose)
Number of subjects: 0
Study: 15955958

Group type: EXPERIMENTAL
Intervention: 500 mg of methylprednisolone (MP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 2,000 mg of methylprednisolone (MP)
Number of subjects: 30
Study: 12025911

Group type: EXPERIMENTAL
Intervention: Micronized purified flavonoid fraction (MPFF) - 450 mg of micronized diosmin and 50 mg of flavonoids expressed in hesperidin for 6 months
Number of subjects: 5052

Group type: COMPARATOR
Intervention: Control group (patients with venous reflux)
Number of subjects: 5052
Study: 10327189

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (100 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 8948610

Group type: EXPERIMENTAL
Intervention: Intralesional interferon-gamma (IFN-G) injections
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 0
Study: 1721887

Group type: EXPERIMENTAL
Intervention: Isovolemic hemodilution over 6 weeks with hydroxyethyl starch solutions (PCV down to 35-32%)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Basic treatment of 75 mg of acetylsalicyclic acid daily
Number of subjects: 21
Study: 6751656

Group type: EXPERIMENTAL
Intervention: 100-g oral glucose load after 3-hour exercise
Number of subjects: 0
Study: 31377382

Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training (G-EO System), 20 sessions of 45 minutes each.
Number of subjects: 96

Group type: COMPARATOR
Intervention: Treadmill training, 20 sessions of 45 minutes each.
Number of subjects: 96
Study: 30174138

Group type: EXPERIMENTAL
Intervention: Circulating vitamin E levels
Number of subjects: 7781
Study: 27567973

Group type: EXPERIMENTAL
Intervention: Child‐ and Family‐Focused Cognitive-Behavioral Therapy (CFF‐CBT)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 69
Study: 24442330

Group type: EXPERIMENTAL
Intervention: EEG analysis using permutation entropy (PeEn)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: EEG sequences evaluated for stationarity
Number of subjects: 15
Study: 22369339

Group type: EXPERIMENTAL
Intervention: Competitive exergame condition
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Cooperative exergame condition
Number of subjects: 54

Group type: COMPARATOR
Intervention: No-play control group
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Weight loss during the intervention
Number of subjects: 54
Study: 20678895

Group type: EXPERIMENTAL
Intervention: Macmillan Approach to Weight and Eating (MAWE)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study: 17685676

Group type: EXPERIMENTAL
Intervention: Group 2 (medicine ball training)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Group 1 (control group with no medicine ball training)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 49
Study: 16168282

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 141
Study: 12060327

Group type: EXPERIMENTAL
Intervention: Rotational technique
Number of subjects: 145

Group type: COMPARATOR
Intervention: Standard 'nonrotational' technique
Number of subjects: 145
Study: 10535235

Group type: EXPERIMENTAL
Intervention: CRAFT approach (community reinforcement and family training)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Al‐Anon facilitation therapy
Number of subjects: 130

Group type: COMPARATOR
Intervention: Johnson Institute intervention
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: All three approaches
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: CRAFT approach
Number of subjects: 130
Study: 7768073

Group type: EXPERIMENTAL
Intervention: Tolcapone 200 mg and higher
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Tolcapone (5 to 800 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Tolcapone
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 3-O-methylmetabolite of tolcapone
Number of subjects: 48
Study: 2382605

Group type: EXPERIMENTAL
Intervention: Urokinase (3.0 million units over 30 minutes intravenously) with maximal antianginal therapy and intravenous heparin
Number of subjects: 31
Study: 393732

Group type: EXPERIMENTAL
Intervention: Mycophenolic acid (MPA)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Mycophenolic acid (MPA) after placebo
Number of subjects: 21
Study: 31898874

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 5145

Group type: COMPARATOR
Intervention: Diabetes support and education (Control)
Number of subjects: 5145
Study: 30953665

Group type: EXPERIMENTAL
Intervention: Intranasal insulin (160 IU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study: 29191800

Group type: EXPERIMENTAL
Intervention: Reminders-presented (high frequency, 14 reminders over 28 days)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Reminders-presented (low frequency, 7 reminders over 28 days)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Reminders-absent
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Acknowledgment of reminders
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Time since acknowledging receipt of a reminder
Number of subjects: 64
Study: 24638884

Group type: EXPERIMENTAL
Intervention: Medication treatment for ADHD
Number of subjects: 66

Group type: COMPARATOR
Intervention: Behavior therapy (BT)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Combined treatment (behavior therapy and/or stimulant medication)
Number of subjects: 66
Study: 23450464

Group type: EXPERIMENTAL
Intervention: Gait speed measured with the 6‐m or 10‐m timed walking test
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Multivariate model including gait speed and fear of falling
Number of subjects: 153
Study: 21592234

Group type: EXPERIMENTAL
Intervention: Alfuzosin 10mg daily for 4 weeks and dologesic (paracetamol+dextropropoxyphene, four tablets daily on demand) for 2 weeks
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group received dologesic for 2 weeks only
Number of subjects: 67
Study: 19779491

Group type: EXPERIMENTAL
Intervention: 160 mg valsartan (V group, n=22)
Number of subjects: 43

Group type: COMPARATOR
Intervention: 80 mg valsartan plus low-dose trichlormethiazide (1 mg) (V+D group, n=21)
Number of subjects: 43
Study: 17159818

Group type: EXPERIMENTAL
Intervention: (18)FDG PET
Number of subjects: 42
Study: 12629458

Group type: EXPERIMENTAL
Intervention: 4 min run
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: static stretch
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: run + stretch
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: run + stretch + practice jumps
Number of subjects: 16

Group type: COMPARATOR
Intervention: control
Number of subjects: 16
Study: 10717350

Group type: EXPERIMENTAL
Intervention: DTP acellular vaccines
Number of subjects: 2163

Group type: EXPERIMENTAL
Intervention: DTP whole cell vaccine
Number of subjects: 2163

Group type: COMPARATOR
Intervention: DT vaccine
Number of subjects: 2163

Group type: EXPERIMENTAL
Intervention: 3, 5, 12 month schedule
Number of subjects: 2163

Group type: EXPERIMENTAL
Intervention: 2, 4, 6 month schedule
Number of subjects: 2163

Group type: EXPERIMENTAL
Intervention: 4-5 years after the third dose
Number of subjects: 2163
Study: 8741950

Group type: EXPERIMENTAL
Intervention: Methadone maintenance (50 mg PO daily)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cocaine challenge doses (0, 12.5, 25, and 50 mg IV)
Number of subjects: 22
Study: 1392359

Group type: EXPERIMENTAL
Intervention: Skin-to-skin with the mother
Number of subjects: 50

Group type: COMPARATOR
Intervention: Separated in a cot
Number of subjects: 50
Study: 3903789

Group type: EXPERIMENTAL
Intervention: Flupenthixol (0.5 to 2 mg a day)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Diazepam (2.5 to 10 mg a day)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Sulpiride (100 to 200 mg a day)
Number of subjects: 113
Study: 30792342

Group type: EXPERIMENTAL
Intervention: Interdisciplinary model of care (smoking cessation support, home medicines review, home-based pulmonary rehabilitation)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 272
Study: 29086478

Group type: EXPERIMENTAL
Intervention: High flavonoid apple (HFA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low flavonoid apple (LFA)
Number of subjects: 30
Study: 26555785

Group type: EXPERIMENTAL
Intervention: Topical ivermectin
Number of subjects: 62

Group type: COMPARATOR
Intervention: Oral ivermectin
Number of subjects: 62
Study: 25637602

Group type: EXPERIMENTAL
Intervention: metoprolol (β1-selective)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: metoprolol+doxazosin (β1/α1)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: carvedilol (β1/β2/α1)
Number of subjects: 47
Study: 23918000

Group type: EXPERIMENTAL
Intervention: Electronic Urticaria Patient Daily Diary (eUPDD)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Paper Urticaria Patient Daily Diary (UPDD)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Urticaria Activity Score (sum of 'itch severity' and 'number of hives')
Number of subjects: 91
Study: 21757939

Group type: EXPERIMENTAL
Intervention: 1 g paracetamol i.v.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 75 mg diclofenac sodium i.m.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 8 mg lornoxicam i.v.
Number of subjects: 60
Study: 18835043

Group type: EXPERIMENTAL
Intervention: Aripiprazole (15‐30 mg/day)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Lithium (900‐1500 mg/day)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study: 16962720

Group type: EXPERIMENTAL
Intervention: Single breath of 35% CO(2)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Air inhalation
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Single breath of 35% CO(2) and ATD combined
Number of subjects: 14
Study: 12531752

Group type: EXPERIMENTAL
Intervention: Semitendinosus tendon graft
Number of subjects: 71

Group type: COMPARATOR
Intervention: Bone-patellar tendon-bone graft
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 71
Study: 10645045

Group type: EXPERIMENTAL
Intervention: abciximab
Number of subjects: 42

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 42
Study: 9513824

Group type: EXPERIMENTAL
Intervention: 2-week course of amoxicillin and tinidazole for index children and siblings younger than 18; 2-week course of Colloidal Bismuth Subcytrate and tinidazole for parents and siblings over 18
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (children with dyspepsia and Helicobacter pylori gastritis whose infected family contacts were not treated)
Number of subjects: 47
Study: 7699213

Group type: EXPERIMENTAL
Intervention: LH‐RH analogs treatment for Group 1 patients (P.A.H. < -1 SDS) for 2 years
Number of subjects: 26

Group type: COMPARATOR
Intervention: No treatment for Group 2 patients (P.A.H. > -1 SDS) for 2 years
Number of subjects: 26
Study: 2646988

Group type: EXPERIMENTAL
Intervention: Daily change of povidone-iodine dressing
Number of subjects: 83

Group type: COMPARATOR
Intervention: Original dressing unchanged (Control)
Number of subjects: 83
Study: 29869460

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 83

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 83
Study: 28199710

Group type: EXPERIMENTAL
Intervention: CBT‐I + antidepressant (AD; escitalopram)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: CBT‐I + placebo pill
Number of subjects: 107

Group type: COMPARATOR
Intervention: AD + 4‐session sleep hygiene control (SH)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 107
Study: 25053587

Group type: EXPERIMENTAL
Intervention: GIP
Number of subjects: 10

Group type: COMPARATOR
Intervention: GLP-1
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 10
Study: 24913347

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 139